Duration of testosterone suppression and
β
Anthony V. D'Amico; Andrew A. Renshaw; Brittany Loffredo; Ming-Hui Chen
π
Article
π
2007
π
John Wiley and Sons
π
English
β 141 KB
π 1 views
## Abstract ## BACKGROUND. The authors evaluated whether the duration of androgen suppression (AS) after the completion of hormone therapy (HT) was associated with the risk of prostate cancerβspecific mortality (PCSM) and allβcause mortality (ACM). ## METHODS. The study cohort was comprised of 2